Publication of Frequently Asked Questions and Answers Guide for Scientific Events
Αναρτάται από το Γραφείο Προέδρου ΔΣ/ΕΟΦ, στο πλαίσιο των αρμοδιοτήτων του, Οδηγός Συχνών Ερωτήσεων και Απαντήσεων (Q&A) στην ελληνική και
Greece EOF · Greece
Jurisdiction
Greece
Regulation
Category
Type · Breadth
Date
Registration procedure for veterinary medicinal products with a centralised marketing authorisation
Please be informed that the procedure required for submission at the national level for the registration of veterinary medicinal products
Greece EOF · GreeceMHSYFA Q2 2026: Proposed Prices for Consultation
Greek EOF pricing department proposes medicinal product prices for Q2 2026, open for public consultation.
Greece EOF · GreecePricing of new pharmaceutical products, Q2 2026: new products, reference product repricing following data protection expiry, and price adjustment requests for non-reimbursed formulations
Greece's EOF pricing department proposes pricing decisions for new medicines, repricing of reference products, and examination of price adjustment requests for non-reimbursed formulations in Q2 2026.
Greece EOF · GreeceTemporary ban on parallel exports and intra-community distribution of medicinal products
Greece imposes a temporary prohibition on parallel exports and intra-community distribution of pharmaceutical products.
Greece EOF · GreeceProcedure for registration of veterinary medicines with central marketing authorisation
Greece's National Medicines Organisation published the procedure and required forms for registering veterinary medicines with central marketing authorisation.
Greece EOF · GreeceMHSYFA Q1 2026: Proposed Prices for Consultation
Greece's EOF pricing department proposes medicinal product prices for Q1 2026, open for public consultation.
Greece EOF · GreeceMHSYFA 2026 Repricing: Proposed prices for consultation
Greece EOF publishes proposed retail prices for MHSYFA products for public consultation.
Greece EOF · GreecePricing of New Pharmaceutical Products – Q2 2026: Re-pricing of reference products following data protection expiry and examination of price adjustment requests for non-reimbursed formulations
Greek EOF pricing department proposes new pricing decisions for Q2 2026 including reference product re-pricing and non-reimbursed formulation price adjustments.
Greece EOF · GreeceGeneric medicines May 2026 – proposed prices for consultation
Greece EOF pricing department proposes generic medicine prices for public consultation.
Greece EOF · GreeceGeneric medicines June 2026 – proposed prices for consultation
Greek EOF pricing department proposes generic medicine prices for public consultation.
Greece EOF · GreecePricing of new pharmaceutical cannabis final products: proposed prices for consultation
Greek EOF invites consultation on proposed pricing for new pharmaceutical cannabis final products.
Greece EOF · GreeceDeclaration of Human Medicinal Product Stocks
Pharmacies are requested to declare their medicinal product inventories on Monday 31 August 2026 at 11:30 AM via online application.
Greece EOF · GreeceList of Medicinal Products with Limited Availability, 31 July 2026
Greece EOF · GreeceMeeting at Greek EOF on smooth operation of pharmaceutical supply chain
Greece EOF · GreeceProcedure for registration and modification of veterinary medicines with central marketing authorisation
Καταχώρηση Άδειας Κυκλοφορίας Για την καταχώριση των κτηνιατρικών φαρμάκων με κεντρική Α.Κ. στην βάση δεδομένων του Ε.Ο.Φ., απαιτείται σε εθνικό
Greece EOF · GreeceRegistration and variation procedure for veterinary medicinal products with a centralised marketing authorisation
Marketing Authorisation Registration (*) For the registration of veterinary medicinal products with a centralised MA in the EOF database, a
Greece EOF · GreeceNew SYFA Q2 2026 — Pharmaceutical Product Pricing (updated 30 July 2026)
Στα πλαίσια της διαδικασίας τιμολόγησης νέων φαρμακευτικών προϊόντων, παρακαλούνται οι κάτοχοι των αδειών κυκλοφορίας αυτών όπως υποβάλλουν από σήμερα Τρίτη
Greece EOF · GreecePRAC Pharmacovigilance Risk Assessment Committee: key points from meeting 6–9 July 2026
Φαρμακευτικά σκευάσματα που περιέχουν δεσογεστρέλη και ετονογεστρέλη: κίνδυνος μηνιγγιώματος και νέα μέτρα ελαχιστοποίησης κινδύνου, Litfulo (ριτλεσιτινίμπη): επικαιροποίηση πληροφοριών προϊόντος για
Greece EOF · GreecePharmaceutical products containing desogestrel and etonogestrel: Direct healthcare professional communication on meningioma risk
Direct healthcare professional communication on meningioma risk associated with desogestrel and etonogestrel-containing products and risk minimisation measures.
Greece EOF · GreeceDeclaration of Human Medicines Stocks
Pharmaceutical wholesalers are requested to declare their stock holdings via online application by 21 July 2026 at 11:30 AM.
Greece EOF · GreeceRecall of affected serial numbers of Newport HT70 and HT70 PLUS ventilators and certain related Newport spare parts
Recall issued for specific serial numbers of Newport HT70 and HT70 PLUS ventilators and related spare parts.
Greece EOF · GreeceRecall of batches of the medical device 'BiCOAG Hemostatic Catheter' by Olympus, class MDD IIb
Batches of Olympus BiCOAG hemostatic catheter (class IIb) are being recalled by the Greek regulatory authority.
Greece EOF · GreeceRecall of batches of Imager II angiographic catheters (Boston Scientific, Class IIa)
Greece EOF recalls batches of Boston Scientific Imager II angiographic catheters, Class IIa medical devices.
Greece EOF · GreeceRecall of batches of polyethylene orthopaedic implant components from Howmedica Osteonics Corp
Greece EOF recalls batches of polyethylene orthopaedic implant components manufactured by Howmedica Osteonics Corp.
Greece EOF · GreeceRecall of batches of medical devices manufactured by BALT EXTRUSION SAS related to ANRYV connectors
Greece EOF recalls batches of medical devices manufactured by BALT EXTRUSION SAS related to ANRYV connectors.
Greece EOF · GreeceRecall of specific serial numbers of Bravo CF capsule placement device, product code FGS-0635
Recall of specific serial numbers of the Bravo CF capsule placement device (product code FGS-0635).
Greece EOF · GreeceRecall of batches of Smartbag-Liquid Acid Concentrates (MDD Class IIb)
Greece EOF recalls specified batches of Smartbag-Liquid Acid Concentrates medical device.
Greece EOF · GreeceRecall of ALPHA nasal oxygen cannula with 2 m delivery tube, REF T20169
Batch recall of ALPHA nasal oxygen cannula with 2 m delivery tube, product code REF T20169.
Greece EOF · GreeceRecall of batches of medical devices: Guedel airway No. 00 (ISO 5.0) and Guedel airway No. 000 (ISO 3.5)
Greece EOF recalls batches of Guedel airway devices (two sizes) due to identified defect or safety issue.
Greece EOF · GreeceRecall of batches of OverStritch Suture Cinch and Suture Cinch-Long (MDD Class IIb suture fastening devices)
Batches of OverStritch Suture Cinch and Suture Cinch-Long Class IIb medical devices recalled by Greek health authority.
Greece EOF · GreeceRecall of batch 272955 of IVD General category medical device, STA-C.K. Prest. kits
Batch 272955 of STA-C.K. Prest. IVD General kits recalled.
Greece EOF · GreeceRecall of batches of the in-vitro diagnostic reagent 'CHORUS Ttg-G'
Greece's EOF recalls batches of the CHORUS Ttg-G in-vitro diagnostic reagent.
Greece EOF · GreeceRecall of batch 240415 (expiry 03/2029) of X-Glove sterile surgical gloves VIOGLOVE PLUS size 7.0 by VIOLAK INTERNATIONAL A.E.
Batch 240415 of sterile surgical gloves recalled due to defect.
Greece EOF · GreeceExtension of suspension of wholesale distribution licence for human medicines: GENIKI FARMAKOAPOTHIKI AE, 12-month extension (until 4 September 2027)
Suspension of the wholesale distribution licence for GENIKI FARMAKOAPOTHIKI AE extended for a further 12 months until 4 September 2027.
Greece EOF · GreeceRecall of batch 2025083000073 of absorbent gauze ZIG ZAG standard 90 cm × 100 m
Batch 2025083000073 of absorbent gauze product recalled by Greek health authority.
Greece EOF · GreecePricing of new generic medicines – Q2 2026
Pricing decisions for new generic medicines (MISYFA) with pricing applications submitted in Q2 2026.
Greece EOF · GreeceProhibition of distribution and supply: Cotton absorbent gauze (REF: 6-1003Ν2 & REF: 6-1006Ν2)
Greece EOF prohibits distribution and supply of specified cotton absorbent gauze products to the market.
Greece EOF · GreeceWarning: NEOFLORAX PLUS MIXED HERBAL BLEND PASTE and BENOIT ORAL JELLY
Greek EOF warns that NEOFLORAX product, distributed online as both medicine and non-medicine, poses safety risk.
Greece EOF · GreeceLITFULO▼ (ritlesitinitimpi): Direct Healthcare Professional Communication
Updated safety recommendations for LITFULO to minimise risk of major cardiovascular events, malignancy, venous thromboembolism, serious infections.
Greece EOF · GreeceProhibition of circulation of TEMPUFEN product by ANTALIA PHARMA MONOPROSOPI I.K.E.
Greece EOF prohibits the circulation of TEMPUFEN pharmaceutical product manufactured by ANTALIA PHARMA MONOPROSOPI I.K.E.
Greece EOF · GreeceRecall of batches of medicinal products CLONOTRIL TABLET 2MG/TAB and METHYLDOPA/REMEDICA F.C.TAB 250MG/TAB
Greece EOF recalls batches of clonidine 2mg tablets and methyldopa 250mg tablets.
Greece EOF · GreeceRecall of batches of the medicinal product BENDAMUSTINE/ACTAVIS PD.C.S.INF 2.5MG/ML BTx1 VIAL (x26ML) x 25MG
Batches of bendamustine/Actavis injection recalled by Greek medicines authority.
Greece EOF · GreeceGeneric medicines May 2026: final proposed prices
Final proposed reimbursement prices for new generic pharmaceutical products from May 2026 applications.
Greece EOF · GreeceRevocation of wholesale distribution licence for human medicines at MENTIKAMERCK AE pharmacy
Wholesale distribution licence for human medicines revoked for MENTIKAMERCK AE pharmacy.
Greece EOF · GreeceRevocation of wholesale distribution licence for human medicines at DEKAZ AE premises
Greece revokes the wholesale distribution licence for human medicines held by DEKAZ AE.
Greece EOF · GreeceList of pharmaceutical preparations with limited availability, 31 August 2026
Greece EOF · GreeceSafety alert: PLUS MIXED HERBAL BLEND PASTE and BENOIT ORAL JELLY
Greece EOF issues safety alert for PLUS MIXED HERBAL BLEND PASTE and BENOIT ORAL JELLY following notification from German authorities.
Greece EOF · Greece
Showing 50 of 57 tracked updates
Health-tech only
See all in the feed →